India’s first trauma haemostat, a wound dressing made of 100% chitosan, a naturally occurring polymer found in shellfish stops bleeding within minutes of being applied; has been developed by Axio Biosolutions Pvt Ltd. The company has designed, developed and commercialised products for Emergency (emergency bleeding control, stop haemorrhage), Military (chitosan sponge for quick clot – haemostatic dressing), Vascular (vascular haemostatic dressing for interventional cardiology/radiology) and Dental (dental dressing – stop oral bleeding, protect wound). Nearly a decade after its inception, this healthcare startup, based out of Bengaluru for the last two years, is revolutionising wound care across the world with the Axiostat Haemostatic Dressing.
“While it looks like dry sponge, when it comes in contact with blood, Axiostat turns sticky and forms an adhesive layer on the blood vessels. All sides of the product are created equal, so there’s no right or wrong side or a prescribed technique to use the product. You just need to take it out of the packaging and place it on the wound. “Blood (has a) net negative (charge) and the product is highly positive, forming a strong adhesive seal,” says founder Mavely. The medical pad comes in multiple sizes—5x5cm, 5x8cm, and 8x8cm—and can stay on the wound for upto 48 hours. The dressing can be removed easily using saline water, leaving no residue.
In a country like India, where roads are poorly maintained and congested, and emergency services are slow, Axiostat could mark the difference between life and death, and that applies to surgical procedures, too. For instance, it normally takes over 30 minutes of manual pressure to plug blood loss following an angioplasty. With Axiostat, however, it can be stopped in just four minutes. Government hospitals and private institutions, including the All India Institute of Medical Sciences (AIIMS), New Delhi, have already begun using the product.
Axio Biosolutions Pvt Ltd is an ISO 13485 certified company with an experienced team focused on bringing high-impact medical products to market and is funded by Accel Partners, IDG Ventures India and Gujarat Venture Finance Ltd.
Previous News
Next News
{{comment.DateTimeStampDisplay}}
{{comment.Comments}}